Brief: Relief Gives Update On Drug For Treatment Of Urea Cycle Disorders

MindMaze Therapeutics Holding SA

18/05/2021 06:21

May 18 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * PROVIDES UPDATE ON PROGRESS AND PLANS WITH ACER-001 FOR
THE
TREATMENT OF UREA CYCLE DISORDERS
    * ACER REMAINS ON TRACK TO SUBMIT AN NDA FOR ACER-001 FOR
TREATMENT OF PATIENTS WITH UCDS IN MID-2021
    * EXPECTS TO DISCUSS ITS PLANS RE ACER-001 WITH EUROPEAN
MEDICINES
AGENCY THIS SUMMER
    * ANTICIPATES SUBMITTING A MARKETING AUTHORIZATION
APPLICATION
(MAA) FOR APPROVAL OF ACER-001 FOR TREATMENT OF UCDS IN EUROPEAN
UNION BEFORE END OF 2021
    * ACER-001 COULD BE LAUNCHED IN BOTH U.S. AND EUROPE DURING
2022

Source text for Eikon:  ID:nEQ75Rc57a 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))